New Zealand markets open in 8 hours 15 minutes

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
146.28-1.12 (-0.76%)
At close: 04:03PM EST
145.98 -0.30 (-0.21%)
Pre-market: 07:27AM EST
Full screen
Trade prices are not sourced from all markets
Previous close147.40
Open147.31
Bid145.75 x 1100
Ask146.88 x 1400
Day's range146.01 - 147.68
52-week range133.05 - 175.91
Volume4,591,481
Avg. volume5,483,988
Market cap258.693B
Beta (5Y monthly)0.62
PE ratio (TTM)19.50
EPS (TTM)7.50
Earnings date09 Feb 2023
Forward dividend & yield5.92 (4.05%)
Ex-dividend date12 Jan 2023
1y target est163.05
  • Motley Fool

    2 of the Best Dividend Stocks to Own in 2023

    In either case, it's a good idea to add some dividend stocks to your portfolio. If you want to benefit from passive income and potential growth, I've got two stocks in mind. The stocks I'm talking about also have reached a turning point that could lead to earnings growth down the road.

  • Motley Fool

    3 Reasons to Buy AbbVie and 2 Reasons Not to Buy

    2023 is expected to be an important year for AbbVie (NYSE: ABBV). The pharmaceutical company is facing its first biosimilar competition in the United States. It's big news because it involves AbbVie's monoclonal antibody blockbuster therapy, Humira, which is on track to generate a second consecutive year of $20 billion-plus in revenue in 2022.

  • Motley Fool

    Want Safety and Growth in 2023? Try These Dividend Stocks.

    Last year was a tough one for most companies and investors. The three major indexes touched bear territory. And even the strongest of companies saw their share prices slip. Everyone is hoping 2023 will bring better days.